← Back to Patent Explorer
US3929989A Expired / Lapsed US ⏱️ 0.0 years remaining

Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis

Assignee: WENDT LAB Inc
•
Filing: 1974-06-14
•
Granted: 1975-12-30
•
Expires: 1994-06-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A therapeutic composition for intrauterine infusion in bovine species in the treatment of metritis is comprised of a suspension of calcium-magnesium oxytetracycline having a molar ratio of combined calcium and magnesium to oxtetracycline of about 4 to 1.

Inventors

  • 👤 Gregory P Bergt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 18:08
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/65

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 57 words
A THERAPEUTIC COMPOSITION FOR INTRAUTERINE INFUSION IN BOVINE SPECIES FOR TREATING METRITIS, WHICH COMPRISES: A STABLE SUSPENSION OF CALCIUM-MAGNESIUM OXYTETRACYCLINE AND HAVING A MOLAR RATIO OF COMBINED CALCIUM AND MAGNESIUM TO OXYTETRACYCLINE OF ABOUT 4-4.3 TO 1, IN AN AQUEOUS SOLVENT OF 1,2 PROPANEDIOL CONTAINING ABOUT 17 PERCENT WATER, AT A PH SUBSTANTIALLY BETWEEN 5.0 AND 11.
Claim 2
Dependent Claim 57 words
A THERAPEUTIC COMPOSITION FOR INTRAUTERINE INFUSION IN BOVINE SPECIES FOR TREATING METRITIS, WHICH COMPRISES: A STABLE SUSPENSION OF CALCIUM-MAGNESIUM OXYTETRACYCLINE AND HAVING A MOLAR RATIO OF COMBINED CALCIUM AND MAGNESIUM TO OXYTETRACYCLINE OF ABOUT 4-4.3 TO 1, IN AN AQUEOUS SOLVENT OF 1,2 PROPANEDIOL CONTAINING ABOUT 17 PERCENT WATER, AT A PH SUBSTANTIALLY BETWEEN 5.0 AND 11.
Claim 3
Dependent Claim 23 words
The composition as defined in claim 1 wherein said molar ratio of combined calcium and magnesium to oxytetracycline is about 4 to 1.
Claim 4
Dependent Claim 21 words
The composition as defined in claim 1 wherein the pH of said composition is within the range of 9.3 to 9.7.

References Cited (Backward Citations)

US3557280A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-12-29 1979-06-30 1979-12-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-12-29 1983-06-30 1983-12-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-12-29 1987-06-30 1987-12-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag